BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 16271752)

  • 1. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of HASH2 (ASCL2) gene expression in gestational trophoblastic disease.
    Shahib MN; Martaadisoebrata D; Kato H
    J Reprod Med; 2006 Nov; 51(11):892-6. PubMed ID: 17165436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
    Sebire NJ; Fisher RA; Williams S; Prendergast G; Savage P; Seckl M
    J Reprod Med; 2008 Oct; 53(10):789-92. PubMed ID: 19004406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of maspin in endometrioid adenocarcinoma of endometrium.
    Li HW; Leung SW; Chan CS; Yu MM; Wong YF
    Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
    Wong SY; Ngan HY; Chan CC; Cheung AN
    Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study.
    Fong PY; Xue WC; Ngan HY; Chan KY; Khoo US; Tsao SW; Chiu PM; Man LS; Cheung AN
    Cancer; 2005 Jan; 103(2):268-76. PubMed ID: 15578716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MMP-2/TIMP-2 expression in the trophoblasts of patients with gestational trophoblastic disease].
    Ding F; Zhang QS; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):150-2. PubMed ID: 17355922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts].
    Qiao C; Cheng DL; Zhang SL; Wang CH; Lin QD
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):839-42. PubMed ID: 15949403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current understandings of the molecular genetics of gestational trophoblastic diseases.
    Li HW; Tsao SW; Cheung AN
    Placenta; 2002 Jan; 23(1):20-31. PubMed ID: 11869089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the p53 gene and apoptosis in gestational trophoblastic disease.
    Halperin R; Peller S; Sandbank J; Bukovsky I; Schneider D
    Placenta; 2000 Jan; 21(1):58-62. PubMed ID: 10692252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma.
    Li AS; Siu MK; Zhang H; Wong ES; Chan KY; Ngan HY; Cheung AN
    Reprod Sci; 2008 Sep; 15(7):735-44. PubMed ID: 18836133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of gestational trophoblastic neoplasia: a review.
    Fulop V; Mok SC; Berkowitz RS
    J Reprod Med; 2004 Jun; 49(6):415-22. PubMed ID: 15283047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of leptin and leptin receptors in gestational trophoblastic diseases.
    Li RH; Yu MM; Cheung AN; Wong YF
    Gynecol Oncol; 2004 Nov; 95(2):299-306. PubMed ID: 15491749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
    Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia.
    Feng HC; Tsao SW; Ngan HY; Xue WC; Kwan HS; Siu MK; Liao XY; Wong E; Cheung AN
    Histopathology; 2008 Jan; 52(2):167-74. PubMed ID: 18184265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.